Missing/wrong data?
Log in to edit
Similar efficacy, safety and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO study
scientific article published on 15 December 2020
Author/s
author: Alan Menter, Petr Arenberger
Work details
Publication date
December 15, 2020
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.